Rupa Radhakrishnan1,2, Nahla M H Elsaid3,4, Senthilkumar Sadhasivam5,6, Thomas A Reher3, Abbey C Hines5,7, Karmen K Yoder3, Andrew J Saykin3, Yu-Chien Wu3. 1. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA. rradhak@iu.edu. 2. Riley Hospital for Children at Indiana University Health, 705, Riley Hospital Drive, Indianapolis, IN, 46202, USA. rradhak@iu.edu. 3. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA. 4. Radiology and Biomedical Engineering, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA. 5. Riley Hospital for Children at Indiana University Health, 705, Riley Hospital Drive, Indianapolis, IN, 46202, USA. 6. Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. 7. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Abstract
PURPOSE: Exposure to prenatal opioids may adversely impact the developing brain networks. The aim of this pilot study was to evaluate alterations in amygdalar functional connectivity in human infants with prenatal opioid exposure. METHODS: In this prospective IRB approved study, we performed resting state functional MRI (rs-fMRI) in 10 infants with prenatal opioid exposure and 12 infants without prenatal drug exposure at < 48 weeks corrected gestational age. Following standard preprocessing, we performed seed-based functional connectivity analysis with the right and left amygdala as the regions of interest after correcting for maternal depression and infant sex. We compared functional connectivity of the amygdala network between infants with and without prenatal opioid exposure. RESULTS: There were significant differences in connectivity of the amygdala seed regions to the several cortical regions including the medial prefrontal cortex in infants who had prenatal opioid exposure when compared with opioid naïve infants. CONCLUSION: This finding of increased amygdala functional connectivity in infants with in utero opioid exposure suggests a potential role of maternal opioid exposure on infants' altered amygdala function. This association with prenatal exposure needs to be replicated in future larger studies.
PURPOSE: Exposure to prenatal opioids may adversely impact the developing brain networks. The aim of this pilot study was to evaluate alterations in amygdalar functional connectivity in human infants with prenatal opioid exposure. METHODS: In this prospective IRB approved study, we performed resting state functional MRI (rs-fMRI) in 10 infants with prenatal opioid exposure and 12 infants without prenatal drug exposure at < 48 weeks corrected gestational age. Following standard preprocessing, we performed seed-based functional connectivity analysis with the right and left amygdala as the regions of interest after correcting for maternal depression and infant sex. We compared functional connectivity of the amygdala network between infants with and without prenatal opioid exposure. RESULTS: There were significant differences in connectivity of the amygdala seed regions to the several cortical regions including the medial prefrontal cortex in infants who had prenatal opioid exposure when compared with opioid naïve infants. CONCLUSION: This finding of increased amygdala functional connectivity in infants with in utero opioid exposure suggests a potential role of maternal opioid exposure on infants' altered amygdala function. This association with prenatal exposure needs to be replicated in future larger studies.
Authors: Nina K Antonov; Carrie B Ruzal-Shapiro; Kimberly D Morel; William S Millar; Sudha Kashyap; Christine T Lauren; Maria C Garzon Journal: Clin Pediatr (Phila) Date: 2016-11-23 Impact factor: 1.168
Authors: Alice M Graham; Jerod M Rasmussen; Marc D Rudolph; Christine M Heim; John H Gilmore; Martin Styner; Steven G Potkin; Sonja Entringer; Pathik D Wadhwa; Damien A Fair; Claudia Buss Journal: Biol Psychiatry Date: 2017-06-19 Impact factor: 13.382
Authors: Magdalena Romanowicz; Jennifer L Vande Voort; Julia Shekunov; Tyler S Oesterle; Nuria J Thusius; Teresa A Rummans; Paul E Croarkin; Victor M Karpyak; Brian A Lynch; Kathryn M Schak Journal: Child Adolesc Psychiatry Ment Health Date: 2019-01-12 Impact factor: 3.033
Authors: Kristen L Benninger; Celine Richard; Sara Conroy; Julia Newton; H Gerry Taylor; Alaisha Sayed; Lindsay Pietruszewski; Mary Ann Nelin; Nancy Batterson; Nathalie L Maitre Journal: Perspect ASHA Spec Interest Groups Date: 2022-06-27
Authors: Carla M Bann; Jamie E Newman; Brenda Poindexter; Katherine Okoniewski; Sara DeMauro; Scott A Lorch; Deanne Wilson-Costello; Namasivayam Ambalavanan; Myriam Peralta-Carcelen; Catherine Limperopoulos; Kushal Kapse; Jonathan M Davis; Michele Walsh; Stephanie Merhar Journal: Pediatr Res Date: 2022-08-30 Impact factor: 3.953
Authors: Rupa Radhakrishnan; Ramana V Vishnubhotla; Zoe Guckien; Yi Zhao; Gregory M Sokol; David M Haas; Senthilkumar Sadhasivam Journal: Neuroradiology Date: 2022-04-12 Impact factor: 2.995
Authors: Rupa Radhakrishnan; Brandon P Brown; David M Haas; Yong Zang; Christina Sparks; Senthilkumar Sadhasivam Journal: J Neuroradiol Date: 2021-01-05 Impact factor: 3.447
Authors: Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham Journal: Neurotoxicol Teratol Date: 2021-09-30 Impact factor: 4.071
Authors: Rupa Radhakrishnan; Ramana V Vishnubhotla; Yi Zhao; Jingwen Yan; Bing He; Nicole Steinhardt; David M Haas; Gregory M Sokol; Senthilkumar Sadhasivam Journal: Front Pediatr Date: 2022-03-14 Impact factor: 3.418